A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis

Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (Mtb) and is a major cause of morbidity and mortality. Successful treatment requires strict adherence to drug regimens for prolonged periods of time. Long-acting (LA) delivery systems have the potential to improve adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Manse, Johnson, Claire E., Schmalstig, Alan A., Annis, Ayano, Wessel, Sarah E., Van Horn, Brian, Schauer, Amanda, Exner, Agata A., Stout, Jason E., Wahl, Angela, Braunstein, Miriam, Victor Garcia, J., Kovarova, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360445/
https://www.ncbi.nlm.nih.gov/pubmed/35941109
http://dx.doi.org/10.1038/s41467-022-32043-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360445/
https://www.ncbi.nlm.nih.gov/pubmed/35941109
http://dx.doi.org/10.1038/s41467-022-32043-3

Ejemplares similares